Shimizu C - Search Results

1

Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells.

Yunokawa M, Koizumi F, Kitamura Y, Katanasaka Y, Okamoto N, Kodaira M, Yonemori K, Shimizu C, Ando M, Masutomi K, Yoshida T, Fujiwara Y, Tamura K. Yunokawa M, et al. Among authors: shimizu c. Cancer Sci. 2012 Sep;103(9):1665-71. doi: 10.1111/j.1349-7006.2012.02359.x. Epub 2012 Aug 1. Cancer Sci. 2012. PMID: 22703543 Free PMC article.

2

[Genetic testing for effective Herceptin therapy].

Watanabe T, Katsumata N, Ando M, Mukai H, Shimizu C, Kitagawa R, Saijo NG. Watanabe T, et al. Among authors: shimizu c. Nihon Rinsho. 2002 Mar;60(3):603-11. Nihon Rinsho. 2002. PMID: 11904980 Review. Japanese.

3

Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.

Saji S, Omoto Y, Shimizu C, Warner M, Hayashi Y, Horiguchi S, Watanabe T, Hayashi S, Gustafsson JA, Toi M. Saji S, et al. Among authors: shimizu c. Cancer Res. 2002 Sep 1;62(17):4849-53. Cancer Res. 2002. PMID: 12208729

4

Clinical impact of assay of estrogen receptor beta cx in breast cancer.

Saji S, Omoto Y, Shimizu C, Horiguchi S, Watanabe T, Funata N, Hayash S, Gustafsson JA, Toi M. Saji S, et al. Among authors: shimizu c. Breast Cancer. 2002;9(4):303-7. doi: 10.1007/BF02967608. Breast Cancer. 2002. PMID: 12459710

5

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.

Shimizu C, Hasegawa T, Tani Y, Takahashi F, Takeuchi M, Watanabe T, Ando M, Katsumata N, Fujiwara Y. Shimizu C, et al. Hum Pathol. 2004 Dec;35(12):1537-42. doi: 10.1016/j.humpath.2004.09.005. Hum Pathol. 2004. PMID: 15619214

6

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer.

Yonemori K, Katsumata N, Uno H, Matsumoto K, Kouno T, Tokunaga S, Yamanaka Y, Shimizu C, Ando M, Takeuchi M, Fujiwara Y. Yonemori K, et al. Among authors: shimizu c. Breast Cancer Res Treat. 2005 Feb;89(3):237-41. doi: 10.1007/s10549-004-2184-0. Breast Cancer Res Treat. 2005. PMID: 15754121

7

Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients.

Kanazawa T, Akashi-Tanaka S, Iwamoto E, Takasugi M, Shien T, Kinoshita T, Miyakawa K, Shimizu C, Ando M, Katsumata N, Fujiwara Y, Fukutomi T. Kanazawa T, et al. Among authors: shimizu c. Breast J. 2005 Sep-Oct;11(5):311-6. doi: 10.1111/j.1075-122X.2005.00003.x. Breast J. 2005. PMID: 16174150

8

The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancer.

Matsumoto K, Katsumata N, Yamanaka Y, Yonemori K, Kohno T, Shimizu C, Andoh M, Fujiwara Y. Matsumoto K, et al. Among authors: shimizu c. Gynecol Oncol. 2006 Feb;100(2):412-6. doi: 10.1016/j.ygyno.2005.10.013. Epub 2005 Nov 18. Gynecol Oncol. 2006. PMID: 16298422

9

[Pharmacogenomics in chemotherapy and drug development for breast cancer].

Shimizu C, Fujiwara Y. Shimizu C, et al. Nihon Rinsho. 2006 Mar;64(3):424-31. Nihon Rinsho. 2006. PMID: 16529031 Review. Japanese.

10

Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients.

Park S, Shimizu C, Shimoyama T, Takeda M, Ando M, Kohno T, Katsumata N, Kang YK, Nishio K, Fujiwara Y. Park S, et al. Among authors: shimizu c. Breast Cancer Res Treat. 2006 Sep;99(1):9-17. doi: 10.1007/s10549-006-9175-2. Epub 2006 Jun 5. Breast Cancer Res Treat. 2006. PMID: 16752223

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

714 results

Search Page

Filters